Development of D4A-based Photoaffinity Probes and Evaluation of their Labeling Abilities to Proteins in the Steroidogenesis Pathway
碩士 === 國立臺灣大學 === 化學研究所 === 107 === Abiraterone, which is an anti-prostate cancer drug approved by US Food and Drug Administration in 2012, can inhibit the enzyme Cytochrome P450 17A1 (CYP17A1) in the stereodogenesis pathway in order to reduce the production of androgens. But it was reported that it...
Main Authors: | Haochen Ren, 任皓晨 |
---|---|
Other Authors: | Chao-Tsen Chen |
Format: | Others |
Language: | zh-TW |
Published: |
2019
|
Online Access: | http://ndltd.ncl.edu.tw/handle/u2v8g8 |
Similar Items
-
Photoaffinity Labeling of Plasma Proteins
by: Masaki Otagiri, et al.
Published: (2013-11-01) -
Synthesis of Multivalent Photoaffinity Probes and Evaluation of Its Labeling Efficiencies with Different Proteins
by: Liu, Tse-Hung, et al.
Published: (2013) -
Photoaffinity labeling of warfarin binding proteins /
by: Myszka, David Gerard
Published: (1991) -
Studies in photoaffinity labelling
by: Seddon, A. P.
Published: (1982) -
Photoaffinity Labels of Daptomycin
by: Williams, Joshua
Published: (2014)